Euro-Med Laboratories Phil., Inc. (PSE:EURO)

Market Cap	4.28B +15.6%
Revenue (ttm)	6.87B +18.5%
Net Income	470.30M +39.3%
EPS	0.11 +37.5%
Shares Out	4.11B
PE Ratio	9.45
Forward PE	n/a
Dividend	0.07 (6.73%)
Ex-Dividend Date	Nov 13, 2025

Volume	34,000
Average Volume	20,450
Open	1.040
Previous Close	1.040
Day's Range	1.030 - 1.040
52-Week Range	0.720 - 1.100
Beta	0.24
RSI	50.73
Earnings Date	Apr 30, 2026

About PSE:EURO

Euro-Med Laboratories Phil., Inc. manufactures and sells various pharmaceutical products in the Philippines and internationally. It manufactures and distributes large and small volume parenterals that are used as solvents for other drugs; sterile water for injection; and other solutions for ophthalmic, inhalation, irrigation, and dialysis. The company also offers specialty fluids comprising dialysis solutions for the treatment of acute or chronic renal failure; hemodialysis solution, a concentrated solution of electrolytes in water for injectio...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1988
• Employees: 1,811
• Stock Exchange: Philippine Stock Exchange
• Ticker Symbol: EURO

Financial Performance

In 2025, PSE:EURO's revenue was 6.87 billion, an increase of 18.50% compared to the previous year's 5.80 billion. Earnings were 470.30 million, an increase of 39.27%.